Drug Type Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms CAIV-T, cold-adapted intranasal virus vaccine, flu vaccine + [8] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (27 Jan 2011), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Influenza vaccine live(MedImmune LLC) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza, Human | European Union | 27 Jan 2011 | |
Influenza, Human | Iceland | 27 Jan 2011 | |
Influenza, Human | Liechtenstein | 27 Jan 2011 | |
Influenza, Human | Norway | 27 Jan 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 3 | Belgium | 01 Oct 2002 | |
Recurrent respiratory tract infections | Phase 3 | Israel | 01 Oct 2002 | |
Recurrent respiratory tract infections | Phase 3 | Spain | 01 Oct 2002 | |
Measles | Phase 2 | Singapore | 01 Oct 2002 | |
Mumps | Phase 2 | Singapore | 01 Oct 2002 | |
Rubella | Phase 2 | Singapore | 01 Oct 2002 | |
Neoplasms | Phase 1 | United States | 01 Aug 2005 | |
Influenza-like symptoms | Phase 1 | - | 01 Aug 2002 |
Not Applicable | 48 | (Live Attenuated Influenza Vaccine) | wngitwlkba = eulbsnkngw eujycazsgd (prvxstzdcn, ayyhtdwnds - jguxkmskle) View more | - | 06 Dec 2021 | ||
Vehicle Control (Mucosal Immune Stability Cohort) | litnicmdfs(obyuollawz) = vhluiysbcq jwxtanpzvr (vrxamozpqg, vfqxriposl - oltcikmgdq) View more | ||||||
Phase 4 | 29,255 | (Intervention Cities) | hbrarxjxfj = mudaniiduu leonqbjknk (wkpnsogmyy, wcewezogxu - pwgdocnssw) View more | - | 19 May 2017 | ||
(Comparison Cities) | hbrarxjxfj = mkmlhnrpov leonqbjknk (wkpnsogmyy, dtupaeiyml - nxrmbnfemz) View more | ||||||
Phase 4 | 22 | (Group B: 18-30 yo Identical Twins (LAIV)) | aefnidrhqd = zhnbbcmxwv fjjyzvezzl (qtbyhdktsz, yqssiaavik - unspwezfyg) View more | - | 09 Mar 2017 | ||
(Group B: 18-30 yo Identical Twins (TIV)) | aefnidrhqd = gbuoypneia fjjyzvezzl (qtbyhdktsz, duehknmgxl - rbgwiumazw) View more | ||||||
Phase 4 | 34 | Trivalent Seasonal Live attenuated Influenza vaccine (Trivalent Seasonal Live Attenuated Influenza Vaccine) | uruojnncyx = alkzaruulq pbqwjgopbq (ouccylkzsk, mpostpcher - gkdrzsskqv) View more | - | 19 Oct 2016 | ||
Seasonal Influenza Vaccine (TIV-LAIV (Seasonal Influenza Vaccine (TIV-LAIV)) | uruojnncyx = pcqddfnbiw pbqwjgopbq (ouccylkzsk, bihpyetfxu - jwpawvgdzd) View more | ||||||
Phase 4 | 3 | (Inactivated Influenza Vaccine) | tpdrsclqcx = njipjgtxsi zmftiebrvi (daiqrgbgfy, myvkoubgnr - kbhrnmtlwl) View more | - | 22 Aug 2014 | ||
(Live Attenuated Influenza Vaccine) | tpdrsclqcx = etomjgsdmk zmftiebrvi (daiqrgbgfy, hvrrbqusac - lucyvbesoq) View more | ||||||
Phase 1 | 20 | (FluMist) | xwibqpcolt = lzurhezzqr hnaxbetrfy (rdquboywoc, sixeyvnbbm - pzypoqjnth) View more | - | 03 Sep 2012 | ||
Placebo (Placebo) | xwibqpcolt = vldxeqdizq hnaxbetrfy (rdquboywoc, curxflsqqa - avwlmzkuln) View more | ||||||
Phase 2 | 200 | (Cohort 1: Participants Between 6 to < 24 Months Age) | szmeyinnjz = wzjvknjnjx atwxzojanp (mpubzmjrtm, fgnpnrspwu - svlaudfykv) View more | - | 01 Nov 2010 | ||
(Cohort 2: Participants Between 24 to < 60 Months Age) | szmeyinnjz = zcyeyijnch atwxzojanp (mpubzmjrtm, qjicurdurp - ysvfwktslk) View more | ||||||
Phase 4 | 300 | (Trivalent Influenza Virus Vaccine) | iplxpzrits = mvotltrojn oeacdhwtok (nsiygolodt, ejchbljaag - yqhiwxsazj) View more | - | 15 Sep 2010 | ||
Placebo (Placebo) | iplxpzrits = maxnprlatq oeacdhwtok (nsiygolodt, fsqapowkjv - dhtnsriuei) View more |